Literature DB >> 23536402

Comparison of the Vitek 2, MicroScan, and Etest methods with the agar dilution method in assessing colistin susceptibility of bloodstream isolates of Acinetobacter species from a Korean university hospital.

Seung Yeob Lee1, Jong Hee Shin, Kyungwon Lee, Min Young Joo, Kyung Hwa Park, Myung Geun Shin, Soon Pal Suh, Dong Wook Ryang, Soo Hyun Kim.   

Abstract

We evaluated three commercial colistin susceptibility testing methods using 213 bloodstream Acinetobacter isolates identified by gene sequencing. Compared to the agar dilution reference method, excellent categorical agreements (both 99.1%) were observed using Vitek 2 and Etest, compared to 87.3% (95.7% for Acinetobacter baumannii and 80.7% for non-baumannii Acinetobacter isolates) using MicroScan.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23536402      PMCID： PMC3716055          DOI： 10.1128/JCM.00427-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  rpoB gene sequencing for identification of Corynebacterium species.

Authors:  Atieh Khamis; Didier Raoult; Bernard La Scola
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii.

Authors:  L A Arroyo; A García-Curiel; M E Pachón-Ibañez; A C Llanos; M Ruiz; J Pachón; J Aznar
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

3.  Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin.

Authors:  T Y Tan; S Y Ng
Journal:  Clin Microbiol Infect       Date:  2007-03-19       Impact factor: 8.067

4.  Variations in colistin susceptibility among different species of the genus Acinetobacter.

Authors:  Alexandr Nemec; Lenie Dijkshoorn
Journal:  J Antimicrob Chemother       Date:  2009-12-11       Impact factor: 5.790

Review 5.  Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.

Authors:  Yun Cai; Dong Chai; Rui Wang; Beibei Liang; Nan Bai
Journal:  J Antimicrob Chemother       Date:  2012-03-22       Impact factor: 5.790

6.  Colistin susceptibility testing: evaluation of reliability for cystic fibrosis isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia.

Authors:  Samuel M Moskowitz; Elizabeth Garber; Yunhua Chen; Sarah A Clock; Setareh Tabibi; Amanda K Miller; Michael Doctor; Lisa Saiman
Journal:  J Antimicrob Chemother       Date:  2010-04-29       Impact factor: 5.790

7.  Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene.

Authors:  Yangsoon Lee; Jinhwa Lee; Seok Hoon Jeong; Jonghan Lee; Il Kwon Bae; Kyungwon Lee
Journal:  J Antimicrob Chemother       Date:  2010-11-03       Impact factor: 5.790

8.  Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species.

Authors:  Jane F Turton; Jayesh Shah; Chika Ozongwu; Rachel Pike
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

9.  In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods.

Authors:  A C Nicodemo; M R E Araujo; A S Ruiz; A C Gales
Journal:  J Antimicrob Chemother       Date:  2004-02-18       Impact factor: 5.790

10.  Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species.

Authors:  Bernard La Scola; Vijay A K B Gundi; Atieh Khamis; Didier Raoult
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948
View more
  18 in total

1.  Identification, genotypic relation, and clinical features of colistin-resistant isolates of Acinetobacter genomic species 13BJ/14TU from bloodstreams of patients in a university hospital.

Authors:  Seung Yeob Lee; Jong Hee Shin; Kyung Hwa Park; Ju Hee Kim; Myung Geun Shin; Soon Pal Suh; Dong Wook Ryang; Soo Hyun Kim
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

Review 2.  Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.

Authors:  Fereshteh Ezadi; Abdollah Ardebili; Reza Mirnejad
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

Review 3.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

4.  Reply to "Reliability of Gradient Diffusion Methods for Detection of Acquired Colistin Resistance".

Authors:  Konstantina Dafopoulou; Olympia Zarkotou; Evangelia Dimitroulia; Christos Hadjichristodoulou; Vasiliki Gennimata; Spyros Pournaras; Athanasios Tsakris
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

5.  Reliability of Gradient Diffusion Methods for Detection of Acquired Colistin Resistance.

Authors:  M Nastro; C Vay; A Famiglietti; C H Rodriguez
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

6.  Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?

Authors:  Shawn Vasoo
Journal:  J Clin Microbiol       Date:  2017-07-19       Impact factor: 5.948

7.  Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and mcr-Positive Enterobacteriaceae: Comparison of Sensititre, MicroScan, Vitek 2, and Etest with Broth Microdilution.

Authors:  Ka Lip Chew; My-Van La; Raymond T P Lin; Jeanette W P Teo
Journal:  J Clin Microbiol       Date:  2017-06-07       Impact factor: 5.948

8.  Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates.

Authors:  Konstantina Dafopoulou; Olympia Zarkotou; Evangelia Dimitroulia; Christos Hadjichristodoulou; Vasiliki Gennimata; Spyros Pournaras; Athanasios Tsakris
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

Review 9.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

10.  Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections.

Authors:  Maria Helena Rigatto; Fabiane J Vieira; Laura C Antochevis; Tainá F Behle; Natane T Lopes; Alexandre P Zavascki
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.